T. Yano, 矢野恒夫, K. Hasegawa, 長谷川功紀, Tatsuhiko Sato, 佐藤達彦, M. Tatsumi, 巽光朗, T. Watabe, 渡部直史, Yuichiro Kadonaga, 角永悠一郎, K. Kabayama, 樺山一哉, K. Fukase, 深瀬浩一, A. Hachisuka, 蜂須賀暁子, Y. Hirabayashi, 平林容子, H. Fujii, 藤井博史, Y. Yonekura, 米倉義晴
{"title":"日本靶向α治疗转化研究的基本原理——利用astatin -211和Actinium-225 -的放射性药物的复兴","authors":"T. Yano, 矢野恒夫, K. Hasegawa, 長谷川功紀, Tatsuhiko Sato, 佐藤達彦, M. Tatsumi, 巽光朗, T. Watabe, 渡部直史, Yuichiro Kadonaga, 角永悠一郎, K. Kabayama, 樺山一哉, K. Fukase, 深瀬浩一, A. Hachisuka, 蜂須賀暁子, Y. Hirabayashi, 平林容子, H. Fujii, 藤井博史, Y. Yonekura, 米倉義晴","doi":"10.3769/radioisotopes.69.329","DOIUrl":null,"url":null,"abstract":"1 QiSS-Targeted Alpha Therapy Research, Research Center for Nuclear Physics, Osaka University, 2 Center for Instrumental Analysis, Kyoto Pharmaceutical University, 3 Nuclear Science and Engineering Center, Japan Atomic Energy Agency, 4 Department of Radiology, Osaka University Hospital, 5 Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, 6 Institute for Radiation Sciences, Osaka University, 7 Department of Chemistry, Graduate School of Science, Osaka University, 8 Division of Biochemistry, National Institute of Health Sciences, 9 Center for Biological Safety & Research, National Institute of Health Sciences, 10 Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center † fam-yano@tcct.zaq.ne.jp","PeriodicalId":20809,"journal":{"name":"Radioisotopes","volume":"110 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rationale for Translational Research on Targeted Alpha Therapy in Japan —Renaissance of Radiopharmaceuticals Utilizing Astatine-211 and Actinium-225—\",\"authors\":\"T. Yano, 矢野恒夫, K. Hasegawa, 長谷川功紀, Tatsuhiko Sato, 佐藤達彦, M. Tatsumi, 巽光朗, T. Watabe, 渡部直史, Yuichiro Kadonaga, 角永悠一郎, K. Kabayama, 樺山一哉, K. Fukase, 深瀬浩一, A. Hachisuka, 蜂須賀暁子, Y. Hirabayashi, 平林容子, H. Fujii, 藤井博史, Y. Yonekura, 米倉義晴\",\"doi\":\"10.3769/radioisotopes.69.329\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1 QiSS-Targeted Alpha Therapy Research, Research Center for Nuclear Physics, Osaka University, 2 Center for Instrumental Analysis, Kyoto Pharmaceutical University, 3 Nuclear Science and Engineering Center, Japan Atomic Energy Agency, 4 Department of Radiology, Osaka University Hospital, 5 Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, 6 Institute for Radiation Sciences, Osaka University, 7 Department of Chemistry, Graduate School of Science, Osaka University, 8 Division of Biochemistry, National Institute of Health Sciences, 9 Center for Biological Safety & Research, National Institute of Health Sciences, 10 Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center † fam-yano@tcct.zaq.ne.jp\",\"PeriodicalId\":20809,\"journal\":{\"name\":\"Radioisotopes\",\"volume\":\"110 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radioisotopes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3769/radioisotopes.69.329\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radioisotopes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3769/radioisotopes.69.329","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rationale for Translational Research on Targeted Alpha Therapy in Japan —Renaissance of Radiopharmaceuticals Utilizing Astatine-211 and Actinium-225—
1 QiSS-Targeted Alpha Therapy Research, Research Center for Nuclear Physics, Osaka University, 2 Center for Instrumental Analysis, Kyoto Pharmaceutical University, 3 Nuclear Science and Engineering Center, Japan Atomic Energy Agency, 4 Department of Radiology, Osaka University Hospital, 5 Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, 6 Institute for Radiation Sciences, Osaka University, 7 Department of Chemistry, Graduate School of Science, Osaka University, 8 Division of Biochemistry, National Institute of Health Sciences, 9 Center for Biological Safety & Research, National Institute of Health Sciences, 10 Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center † fam-yano@tcct.zaq.ne.jp
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
